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Introduction 
Recently, an increasing number of research teams arc 
engaged in developing DNA-based diagnostic techniques 
for mollusc pathogens. These techniques are slowly moving 
from development in specialised laboratories for research 
purposes, to routine application and are expected to find an 
increasing use in routine disease monitoring programs in 
mollusc aquaculture and in efforts to prevent the spread of' 
pathogens within and between nations. Considering the 
probable development and interest in these diagnostic 
techniques, the potential for wide applications in 
aquaculture and the inherent problems currently associated 
with their use, it appears necessary to address these issues. 
The objectives of the workshop, held during the ninth 
conference of the European Association of Fish 
Pathologists ( 19-24 September 1999), were to : 
Evaluate needs f'or molecular diagnostic techniques for the 
principal diseases of molluscs. 
Identify areas where the introduction and use of molecular 
and related technologies (DNA-based and immunological) 
are likely to have a significant impact on improving 
mollusc disease diagnosis. 
Review the status of research towards meeting these needs. 
Make recommendations for research programs to be 
developed to produce, standardise and validate molecular 
diagnostic tools for major mollusc pathogens. 
World 1110!/usc aquaculture and detrimental impact of 
diseases 
Aquaculture of molluscs has been growing at an average 
annual rate of 11 % over the past decade, compared to 
capture fisheries which showed only 1.6% annual growth. 
In 1997, global mollusc aquaculture production rose to 8.5 
million metric tons. Main productions are oysters (36% of 
the total mollusc production), clams (23%), scallops (15%), 
and mussels ( 13%). Recently, annual growth in production 
has been rapid; 16% for clams, 20% for abalones, but only 
3'% for mussels. This growing rate is to be considered as a 
key point for zoosanitary risks in molluscan aqua~ulture. In 
fact, mollusc farming is traditionally based on :v1!d stocks, 
but natural populations frequently do not sat1sty 1~1arket 
demand because of overfishing, low value species or 
disease outbreaks. An answer to this situation has been the 
introduction of new stocks or species. Introductions of 
non-native stocks can, however, result in the simultaneous 
introduction of new pathogens or strains: . • . 
Disease outbreaks are recognised as a s1g111ficant constramt 
to aquaculture production and trade, affe~ting both the, 
economic development and socio-economic re~enu~ ot 
many countri~s. Mollusc farming in many countries laces 
serious disease problems resulting in significant P'.·oducti~n 
losses. Pathogen transfers via movements. ot aquatic 
organisms appear to be an important underlymg cause of 
such epizootics. One of the very few way~ to reduce. the 
impact or such pathogens on commercially expl01ted 
bivalves is to establish effective programs to prevent the 
transfer or infected stocks. Consequently, a region or 
country where molluscs are infected with any of these 
pathogens should not be allowed to expmi into another area 
free of this disease. In addition to the routine surveillance 
of stocks, country imports and abnormal mortalities in 
mollusc should be examined for the presence of pathogens. 
Diagnosis of rnollusc diseases andpossible development of 
molecular tools · 
The effective control of diseases of bivalve molluscs 
requires access to diagnostic tests that are rapid, reliable 
and sensitive. Techniques applicable to molluscan 
pathogens are limited, and most of the investigations are 
based on histological and ultrastructural examinations. 
However, many pathogens are difficult to detect and 
recognise, particularly at low numbers, using such methods 
Recent efforts to overcome these problems have led to th~ 
development of immunoassays and nucleic acid based 
di!1g~ostic m_e~h?ds. The~e techniques offer the advantages 
o( h1gl_1 sens1,t1V1ty a.nd high specificity, and possible rapid 
scrcemng ?f aquatic organisms for the presence of a 
pathogen. fo date, gene probes used in the diagnosis f 
diseases of cultured molluscs have been for detection oftl~e 
most economically important pathogens. 
A three tier exami1~~tion procedure is currently 
rec?m1~1ended by th~ Ofhce International des Epizooties, 
which mcludes surveillance, presumptive and confirmation 
methods. Surveillance of mollusc diseases is routine] 
performed by histology. Histology should be used befor~ 
and beside any other type of examination because this 
technique provides a large amount of infrrniiation. 
Mortality is often associated with the presence O f several 
patho~ens in bi:alves or loss of condition following 
spaw111ng, and this can m~ly be determined by histology. 
When abnormal mortality outbreaks occur, various 
presumptive diagnostic methods such as tissue imprints, 
squashes (~r smet~rs can be used. in addition to histology 
because o( the qmck answer provided by these techniques. 
When a pathogen is encountered in the course or routine 
su.rveillance or mortality outbreak studies, electron 
microscopy and/or molecular probes when available may 
be necessary for specilic identification. 
DNA is a useful molecule to target for diagnostic 
proc~~urcs because its sequence docs not usually vary with 
the hfe stage or developmental phase of the pathooen or 
with the host or tissue location. Not all regions :)f the 
DNA, however, are equally useful as targets for probes 
and/or PCR primers. Closely related organisms have a hioli 
degree of sequence similarity, making the development ~f 
specific probes and primers difficult. The development or 
species specific molecular diagnostic tools will be 
facilitated as sequences for more genes and pathogens 
become known. Often, however, when DNA sequences 
have been determined by different laboratories they do not 
correspo~d to the_ same gene or region of a gene, impeding 
taxonomic studies and sequence comparisons for 
development of diagnostics (e.g. Perki11s11s atlanticus, P. 
o/seni and P. mari1111s). Efforts should be made to obtain 
the same regions of sequences from related organisms to 
optimise the chance of developing probes and PCR primers 
: 
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with the desired specificity. Furthermore, to minimise the 
possibility of species-specific molecular diagnostics faili_ng 
to detect a particular strain of a pathogen, as many strams 
as possible from a wide geographic range should _be 
sequenced. There is a need for internati_onal c~)-ope:at1ve_ 
programs that aim to assess the _taxono_1mc relatJ01:sh1ps ot 
major pathogens and to determme their geo~r~1:h1c range. 
Some of these programs were recently 1111tiated ( e.g. 
Marteilia project, Mikrocell project). 
Some genes, such as the small-subunit ribosomal RNA 
gene, have been sequenced for_ some molluscan parasit_es 
(e.g. Haplosporidium nelsom and H. costale) for 
phylogenetic studies to help clarify the taxonomy and 
biology of these pathogens. In addition, the rRNA genes 
are often useful targets for diagnostic tests because there 
are many copies in the genome, which can help to ensure 
good sensitivity. The identification and use of virulence 
genes as targets of diagnostic tools could allow a more 
relevant assessment of the risk posed by the organism ( e.g. 
Perkinsus spp.). However, the differential expression of 
virulence genes may need to be considered. The 
identification of such genes has been undertaken in very 
few cases; however, it appears as a promising field of 
investigation: 
In situ hybridisation is useful to detect light infections or to 
confirm the identity of a pathogen in a histological section. 
Therefore it is important that laboratories with 
appropriately fixed tissues archive this material in case it is 
needed in the future. Two other issues addressed by in situ 
hybridisation are mixed infections and latent infections. 
Consequently, many laboratories or national/regional 
reference laboratories could adopt in situ hybridisation in 
the next few years as a confirmatory technique. However, 
there is a need for standard and validated protocols. These 
protocols should include negative and positive controls. 
The latter would provide valuable information on the 
quality of the DNA molecule in the sample. 
The Polymerase Chain Reaction (PCR) is an emerging 
molluscan disease diagnostic technique that currently 
should be used in addition to other techniques. Major 
benefits of PCR techniques include rapid results, high 
sensitivity and high specificity. In addition, if the sequence 
is known, amplification of DNA fragments and subsequent 
sequence analysis can help to identify an unknown 
pathogen and even confirm infections in a different host. 
Problems with PCR are that light infections may be missed 
if tissue is subsampled or inhibitory factors in mollusc 
tissues may give false negative results. In addition, the 
extreme sensitivity of PCR may result in a positive result 
even when a viable pathogen is not present. More research 
is needed on PCR results in conjunction with other 
diagnostic techniques before PCR can be recommended as 
the technique of choice. Again, positive and negative 
controls as well as internal controls must be included in the 
protocols. PCR is a potentially useful technique for 
screening pooled samples of seeds. Reference laboratories 
must consider the processing of incoming material, as 
improperly fixed tissues ( e.g. in fixative longer than 24-48 
hours) are not suitable if PCR is needed later for pathogen 
identification. 
Conclusion 
The further development and use of DNA based diagnostic 
techniques holds promise for efforts to control the 
introduction of exotic diseases in other geographic areas. 
Reliable and rapid techniques are needed by national and 
regional diagnostics laboratories to screen imported fish 
and shellfish for important pathogens. Therefore, it is of 
central importance to develop molecular diagnostic 
techniques for major mollusc pathogens. On the other hand, 
the routine use of QNA based diagnostic techniques is 
hampered by a number of problems, which may result in 
false positive, or false negative results. Efforts must be 
made to develop, validate and standardise rapid diagnostic 
techniques for major mollusc diseases and pathogens. 
